Since mid-2016, Pharos has been working closely with South Africa’s National Department of Health (NDOH) and local clinicians as they develop their national viral hepatitis prevention and treatment guidelines and five-year strategic plan for both HBV and HCV. In particular, Pharos has been focused on the translation of these documents into a 5-year Action Plan. We developed the Action Plan using an investment case framework where we synthesized detailed costing, projected impact, cost-effectiveness analysis, and financing and budget impact analysis into a cohesive narrative that makes the case for why hepatitis investments would be affordable and reduce a significant burden of disease in South Africa. Pharos continues to support South Africa to make evidence-based decisions regarding hepatitis policy-making and programming, and to secure additional funding for launching a national hepatitis program in South Africa.
Below the tables from the publication are shown.
Team members: Lindsey Hiebert, Wendy Spearman, Mark Sonderup, Teresa Guthrie, Tim Hallett, Shevanthi Nayagam, Homie Razavi, Shan Soe-Lin, Kgomotso Vilikazi-Nhlapo, Yogan Pillay, Stephen Resch, Rob Hecht